Dark Forest Capital Management LP Madrigal Pharmaceuticals, Inc. Transaction History
Dark Forest Capital Management LP
- $634 Million
- Q4 2024
A detailed history of Dark Forest Capital Management LP transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Dark Forest Capital Management LP holds 1,286 shares of MDGL stock, worth $437,072. This represents 0.06% of its overall portfolio holdings.
Number of Shares
1,286Holding current value
$437,072% of portfolio
0.06%Shares
4 transactions
Others Institutions Holding MDGL
# of Institutions
334Shares Held
22.3MCall Options Held
960KPut Options Held
940K-
Janus Henderson Group PLC London, X02.21MShares$751 Million0.36% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.04MShares$694 Million38.14% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.03MShares$690 Million9.12% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$678 Million10.03% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$671 Million6.75% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $5.81B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...